{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:10:00Z","timestamp":1790165400660,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.clinthera.2012.11.006","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T13:18:22Z","timestamp":1354195102000},"page":"2268-2278","source":"Crossref","is-referenced-by-count":63,"title":["GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis\u2014Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study"],"prefix":"10.1016","volume":"34","clinical-trial-number":[{"clinical-trial-number":"nct01699555","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Fran\u00e7ois","family":"Curtin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois B.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Perron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Laumonier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9 C.","family":"Porchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.11.006_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.clinthera.2012.11.006_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1741-7015-7-74","article-title":"Recent developments in multiple sclerosis therapeutics","volume":"7","author":"Spain","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2012.11.006_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0923-2516(89)80141-4","article-title":"Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles","volume":"140","author":"Perron","year":"1989","journal-title":"Res Virol"},{"key":"10.1016\/j.clinthera.2012.11.006_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0140-6736(91)92579-Q","article-title":"Isolation of retrovirus from patients with multiple sclerosis","volume":"337","author":"Perron","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2012.11.006_bib5","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.94.14.7583","article-title":"Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis","volume":"94","author":"Perron","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2012.11.006_bib6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/1352458510376956","article-title":"Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis","volume":"16","author":"Sotgiu","year":"2010","journal-title":"Mult Scler"},{"issue":"Pt 1","key":"10.1016\/j.clinthera.2012.11.006_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1099\/vir.0.81890-0","article-title":"Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus\/HERV-W endogenous retrovirus, but not Human herpesvirus 6","volume":"88","author":"Mameli","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.clinthera.2012.11.006_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/1352458512441381","article-title":"Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease","author":"Perron","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.clinthera.2012.11.006_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/13550280390173328","article-title":"Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model","volume":"9","author":"Firouzi","year":"2003","journal-title":"J Neurovirol"},{"key":"10.1016\/j.clinthera.2012.11.006_bib10","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.4049\/jimmunol.176.12.7636","article-title":"The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14\/TLR4 and promotes Th1-like responses","volume":"176","author":"Rolland","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2012.11.006_bib11","unstructured":"Kremer D, Schichel T, Bernard C, et al. The role of the multiple sclerosis associated retrovirus (MSRV) envelope protein (ENV) in oligodendroglial homeostasis and differentiation. Presented at: ARSEPsymposium.Paris,France;2011. Poster."},{"key":"10.1016\/j.clinthera.2012.11.006_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2990.2006.00781.x","article-title":"Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis","volume":"33","author":"Leech","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.clinthera.2012.11.006_bib13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jnnp.56.4.356","article-title":"Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis","volume":"56","author":"McLean","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2012.11.006_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI106279","article-title":"Metabolic properties of IgG subclasses in man","volume":"49","author":"Morell","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2012.11.006_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2125.2008.03187.x","article-title":"The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?","volume":"66","author":"Newsome","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2012.11.006_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/clpt.2008.170","article-title":"Monoclonal antibody pharmacokinetics and pharmacodynamics","volume":"84","author":"Wang","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2012.11.006_bib17","series-title":"Basic & Clinical Pharmacology","first-page":"34","article-title":"Pharmacokinetics & Pharmacodynamics: Rational Dosing & the Time Course of Drug Action","author":"Holford","year":"2004"},{"key":"10.1016\/j.clinthera.2012.11.006_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/11531280-000000000-00000","article-title":"Clinical pharmacokinetics of therapeutic monoclonal antibodies","volume":"49","author":"Keizer","year":"2010","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812006492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812006492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T22:57:20Z","timestamp":1540076240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291812006492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0149291812006492"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.11.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}